Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 23% ± 5% | |
endothelial cell | 4 studies | 19% ± 4% | |
GABAergic neuron | 3 studies | 29% ± 5% | |
glutamatergic neuron | 3 studies | 40% ± 3% | |
astrocyte | 3 studies | 22% ± 4% | |
oligodendrocyte | 3 studies | 20% ± 0% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 29% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1488.47 | 459 / 459 | 100% | 16.62 | 1118 / 1118 |
esophagus | 100% | 1219.07 | 1445 / 1445 | 100% | 9.12 | 183 / 183 |
brain | 100% | 987.57 | 2640 / 2642 | 100% | 12.36 | 705 / 705 |
prostate | 100% | 1309.05 | 245 / 245 | 100% | 12.93 | 501 / 502 |
lung | 100% | 1123.83 | 576 / 578 | 100% | 9.85 | 1155 / 1155 |
kidney | 100% | 951.91 | 89 / 89 | 100% | 10.84 | 897 / 901 |
ovary | 100% | 1573.54 | 180 / 180 | 100% | 6.94 | 428 / 430 |
thymus | 100% | 1416.49 | 653 / 653 | 100% | 14.37 | 602 / 605 |
uterus | 100% | 1582.52 | 170 / 170 | 99% | 10.38 | 456 / 459 |
pancreas | 100% | 732.00 | 327 / 328 | 99% | 10.20 | 177 / 178 |
bladder | 100% | 1356.00 | 21 / 21 | 99% | 9.26 | 499 / 504 |
liver | 100% | 1044.91 | 226 / 226 | 99% | 7.68 | 401 / 406 |
intestine | 100% | 1404.67 | 966 / 966 | 98% | 8.61 | 518 / 527 |
adrenal gland | 100% | 1305.97 | 258 / 258 | 98% | 10.39 | 226 / 230 |
stomach | 100% | 1011.95 | 359 / 359 | 98% | 8.49 | 281 / 286 |
skin | 100% | 1541.82 | 1809 / 1809 | 97% | 10.82 | 460 / 472 |
adipose | 100% | 1353.00 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1351.19 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 10.22 | 29 / 29 |
spleen | 100% | 1380.16 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.26 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.11 | 1 / 1 |
muscle | 99% | 641.18 | 797 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 704.93 | 849 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 6.10 | 74 / 80 |
peripheral blood | 79% | 703.21 | 732 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045664 | Biological process | regulation of neuron differentiation |
GO_0007283 | Biological process | spermatogenesis |
GO_0006397 | Biological process | mRNA processing |
GO_0006402 | Biological process | mRNA catabolic process |
GO_1901533 | Biological process | negative regulation of hematopoietic progenitor cell differentiation |
GO_0001510 | Biological process | RNA methylation |
GO_0061157 | Biological process | mRNA destabilization |
GO_0048255 | Biological process | mRNA stabilization |
GO_0021861 | Biological process | forebrain radial glial cell differentiation |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0019827 | Biological process | stem cell population maintenance |
GO_0042063 | Biological process | gliogenesis |
GO_0016556 | Biological process | mRNA modification |
GO_0045727 | Biological process | positive regulation of translation |
GO_0005654 | Cellular component | nucleoplasm |
GO_0036396 | Cellular component | RNA N6-methyladenosine methyltransferase complex |
GO_0005634 | Cellular component | nucleus |
GO_1904047 | Molecular function | S-adenosyl-L-methionine binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0001734 | Molecular function | mRNA m(6)A methyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | METTL14 |
Protein name | Methyltransferase 14, N6-adenosine-methyltransferase subunit N6-adenosine-methyltransferase non-catalytic subunit (Methyltransferase-like protein 14) (hMETTL14) N6-adenosine-methyltransferase non-catalytic subunit (Methyltransferase-like protein 14) |
Synonyms | KIAA1627 |
Description | FUNCTION: The METTL3-METTL14 heterodimer forms a N6-methyltransferase complex that methylates adenosine residues at the N(6) position of some mRNAs and regulates the circadian clock, differentiation of embryonic stem cells and cortical neurogenesis . In the heterodimer formed with METTL3, METTL14 constitutes the RNA-binding scaffold that recognizes the substrate rather than the catalytic core . N6-methyladenosine (m6A), which takes place at the 5'-[AG]GAC-3' consensus sites of some mRNAs, plays a role in mRNA stability and processing . M6A acts as a key regulator of mRNA stability by promoting mRNA destabilization and degradation (By similarity). In embryonic stem cells (ESCs), m6A methylation of mRNAs encoding key naive pluripotency-promoting transcripts results in transcript destabilization (By similarity). M6A regulates spermatogonial differentiation and meiosis and is essential for male fertility and spermatogenesis (By similarity). M6A also regulates cortical neurogenesis: m6A methylation of transcripts related to transcription factors, neural stem cells, the cell cycle and neuronal differentiation during brain development promotes their destabilization and decay, promoting differentiation of radial glial cells (By similarity). . FUNCTION: The METTL3-METTL14 heterodimer forms a N6-methyltransferase complex that methylates adenosine residues at the N(6) position of some mRNAs and regulates the circadian clock, differentiation of embryonic stem cells and cortical neurogenesis. In the heterodimer formed with METTL3, METTL14 constitutes the RNA-binding scaffold that recognizes the substrate rather than the catalytic core. N6-methyladenosine (m6A), which takes place at the 5'-[AG]GAC-3' consensus sites of some mRNAs, plays a role in mRNA stability and processing. M6A acts as a key regulator of mRNA stability by promoting mRNA destabilization and degradation. In embryonic stem cells (ESCs), m6A methylation of mRNAs encoding key naive pluripotency-promoting transcripts results in transcript destabilization. M6A regulates spermatogonial differentiation and meiosis and is essential for male fertility and spermatogenesis. M6A also regulates cortical neurogenesis: m6A methylation of transcripts related to transcription factors, neural stem cells, the cell cycle and neuronal differentiation during brain development promotes their destabilization and decay, promoting differentiation of radial glial cells. . |
Accessions | ENST00000388822.10 A0A0D9SF88 D6RBL4 D6RD73 ENST00000508801.1 ENST00000626212.2 Q9HCE5 ENST00000506780.2 A0A0D9SFW0 ENST00000628452.2 |